Skip to main content
. 2022 Dec 16;10(35):13129–13137. doi: 10.12998/wjcc.v10.i35.13129

Table 1.

Case reports describing concurrent hepatocellular carcinoma and neuroendocrine carcinomas

Age Symptoms Virus AFP Diagnosis2 Type Therapy Time1 (Mon) Status Ref.
1 43 Abdominal swelling HBV NA Autopsy2 Combined Adriamycin, 5-FU 26 Death Barsky et al[8]
2 69 Abdominal pain HBV NA FNA2 Combined NA NA NA Artopoulos et al[10]
3 63 Abdominal pain, jaundice NA NA Resection Combined NA 1 Death(bleeding spesis) Vora et al[11]
4 72 NA HCV 13.6 Resection, LND Collision NA NA NA Ishida et al[2]
5 71 NA HCV 20.7, 479.1 Resection Combined (intermingled) NA 5 NA Yamaguchi et al[6]
6 50 NA HCV 1191 Core biopsy, then Resection Collision TACE, cisplatin, doxorubicin, thalidomide and Avastin 16 alive Garcia et al[1]
7 65 Epigastric pain HBV Normal Resection, LND Combined NA 12 Death Yang et al[7]
8 68 NA HBV 1191 Resection Collision Cisplatin, etoposide 28 Alive Tazi et al[4]
9 76 Echo-detected HCV 281.4, 14.9, 2632 (after TACE) TACE, resection Combined NE with sarcomatous change TACE, epirubicin lipiodol 17 Death Nakanishi et al[5]
10 51 Abdominal pain HCV NA Biopsy Combined NA 1 Death Hammedi et al[12]
11 56 Abdominal distension NA 70 Resection Combined NA 6 Alive Aboelenen et al[13]
12 72 No symptoms HCV 24.8 Resection Collision Cisplatin, etoposide 2 Death Nishino et al[14]
13 72 No symptoms HCV 3.8 Resection Collision Cisplatin, etoposide 10 Alive Choi et al[15]
14 76 NA NA 49.2 Resection Collision Cisplatin NA Alive Baker et al[9]
15 71 NA HCV 4791 Resection Combined NA 8.6 Death Nomura et al[16]
16 71 NA HCV 10.3 Resection Collision NA 2.6 Death Nomura et al[16]
17 58 NA HBV 176.4 RFA, Resection Combined NA 19.7 Alive Nomura et al[16]
18 50 NA HBV 473.7 Resection Combined NA 19.5 Alive Nomura et al[16]
19 63 NA HCV 2276 Resection Combined NA 24 Alive Nomura et al[16]
20 65 Abdominal discomfort HCV 400.06 Resection Collision NA 1.3 Death Liu et al[17]
21 70 Solid mass HCV 3.7 TAE and TPE, Resection Collision and combined NA 3 Death Okumura et al[18]
22 56 Incidental NA 2.8 Liver transplantation (Resection specimen) Collision NA 10 Alive Yılmaz et al[3]
23 79 Abnormal liver function NA 3231.8 Resection Combined NA 4 Death Ikeda et al[19]
24 84 Higher AFP values NA 399 Laparoscopic resection Combined NA 9 Alive Nakano et al[20]
25 48 Incidental HBV 29.91 RFA, TACE, RFA, Resection Collision Chemotherapy 40 Death (sepsis) Our study
1

Time in months (since diagnosis).

2

Diagnosis: All are hepatocellular carcinoma (HCC) coexisting with neuroendocrine tumors except the two (2): HCC with carcinoid. NA: None, or not included or not available; HBV: Hepatitis B virus; HCV: Hepatitis C virus; AFP: Alpha-fetoprotein (ng/mL); FNA: Fine needle aspiration; 5-FU: 5-fluorouracil; TACE: Transarterial chemoembolization; TAE: Transarterial embolization; TPE: transportal vein embolization.